Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition [Seeking Alpha]
Tandem Diabetes Care (NASDAQ:TNDM) had its "hold" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $27.00 price target on the stock, up previously from $24.00.
Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Lake Street Capital from a "hold" rating to a "buy" rating.
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..